ProCE Banner Activity

Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events

Slideset

In these downloadable slides, a leading expert provides information on how to identify and mitigate HER3-targeted therapy–related AEs in patients with NSCLC.

Released: December 05, 2024

Expiration: December 04, 2025

Share

Faculty

Karen Reckamp

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Professor, Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.